High-Risk Pregnancy Society Issues Guidance Defining Abortion as Core Obstetric Care

Key facts

The new clinical guidance from the Society for Maternal-Fetal Medicine establishes a clear professional framework for maternal-fetal subspecialists operating under restrictive state abortion laws. According to reporting by Medical Xpress, the leadership of SMFM framed the provision of pregnancy termination and associated counseling not as an optional or peripheral service, but as an indispensable pillar of maternal-fetal clinical practice.

The guidance addresses the clinical reality faced by maternal-fetal medicine doctors, who regularly diagnose severe fetal structural anomalies, genetic conditions, and life-threatening maternal medical complications such as preeclampsia, premature rupture of membranes, and severe cardiovascular disease. In such scenarios, continuing a pregnancy can carry extreme risks to patient health or survival, or may involve a non-viable fetus. The SMFM document explicitly advises specialists to prioritize patient safety and health outcomes by offering full, non-directive counseling on all management options, including termination, and facilitating care or referrals wherever legally permissible.

Furthermore, the document urges subspecialists to navigate statutory restrictions proactively rather than preemptively withholding care out of fear of legal repercussions. By outlining the standard of care for high-risk pregnancies, SMFM aims to provide medical legal cover for physicians facing ambiguous state statutes that exempt care only under narrow emergency exceptions. The guidance emphasizes that failing to counsel patients on pregnancy termination or delaying necessary intervention until a patient becomes critically ill compromises fundamental ethical principles of patient autonomy and non-maleficence.

Why it matters

The consensus statement carries profound implications for clinical decision-making, patient outcomes, and medical risk management across the United States. Maternal-fetal medicine specialists care for the roughly ten to fifteen percent of pregnancies classified as high risk, involving conditions where maternal or fetal life is threatened. When state bans restrict physician discretion, the clinical distinction between life-saving medical intervention and prohibited abortion care becomes dangerously blurred.

For patients, the guidance seeks to ensure that state legal environments do not completely strip away access to evidence-based medical advice. Patients diagnosed with catastrophic fetal abnormalities or severe maternal medical conditions often require timely counseling to make informed choices. Without clear guidance from national specialty societies, healthcare providers may hesitate to discuss pregnancy termination, delaying care or forcing patients to travel across state lines while experiencing severe medical distress.

For medical institutions and liability insurers, the SMFM position creates a benchmark for standard care. Hospital risk management departments frequently push clinical teams toward conservative interpretations of state laws to avoid criminal exposure. By formally defining abortion care as intrinsic to maternal-fetal medicine, SMFM establishes an authoritatively recognized standard that clinicians can reference when advocating for necessary care within hospital ethics committees and legal consultations.

The guidance also addresses growing strains on medical education. Subspecialized fellowship programs in states with broad abortion bans face accreditation challenges regarding comprehensive surgical and medical training, threatening the future supply of high-risk obstetricians in areas already suffering from severe maternal care shortages.

Maternal-fetal medicine emerged as a distinct subspecialty of obstetrics and gynecology in the 1970s, formalized by the American Board of Obstetrics and Gynecology. Specialists in this field complete four years of general obstetrics and gynecology residency followed by three years of intensive fellowship training focusing on advanced ultrasound imaging, fetal therapy, genetics, and maternal medical disorders. The Society for Maternal-Fetal Medicine, established in 1977, serves as the primary professional organization for more than 5,000 members globally, setting clinical guidelines and advocating for maternal health equity.

The legal landscape governing pregnancy care underwent a fundamental shift in June 2022, when the U.S. Supreme Court decided Dobbs v. Jackson Women's Health Organization, overturning the nearly 50-year constitutional right to abortion established in Roe v. Wade (1973). The decision allowed individual states to ban or severely restrict abortion, leading more than a dozen states to enact near-total prohibitions on the procedure, many with severe criminal penalties for medical providers, including felony charges and license revocation.

Although most state statutes contain exceptions to save the life of the pregnant patient, the language of these exceptions is frequently vague, failing to specify what degree of risk or deterioration constitutes a medical emergency. This ambiguity created severe friction between state prosecutors and medical professionals, resulting in documented cases of delayed care for ectopic pregnancies, incomplete miscarriages, and severe pre-viable premature rupture of membranes.

Federal attempts to clarify clinical obligations, such as the Department of Health and Human Services' interpretation of the Emergency Medical Treatment and Labor Act (EMTALA)—a 1986 federal statute requiring Medicare-funded hospitals to provide stabilizing emergency treatment—have faced legal challenges from several state attorneys general, leaving physicians in a legal gray zone between federal mandates and state criminal law.

Reaction

The release of the guidance from the Society for Maternal-Fetal Medicine has drawn predictable align-and-divide responses across the medical, legal, and political landscapes. Major professional medical organizations, including the American College of Obstetricians and Gynecologists (ACOG) and the American Medical Association (AMA), consistently maintain that political interference in clinical care undermines patient safety and the patient-physician relationship. Medical educators and specialty fellows have welcomed the statement, noting that explicit guidance from SMFM reinforces professional norms and aids training accreditation efforts in restrictive states.

Conversely, anti-abortion advocacy groups and conservative state officials are expected to criticize the stance. Opponents of broad abortion access often contend that medical guidelines should strictly adhere to state statutory definitions and argue that pregnancy termination should not be classified as routine healthcare, even in high-risk subspecialties. Conservative legal institutions may view the guidance as an attempt by national medical boards to circumvent state legislative authority.

At the hospital level, clinical leadership and legal defense counsel face the task of translating SMFM's national position into actionable hospital protocols that mitigate statutory criminal risk while upholding clinical ethics and medical board standards.

What we don't know yet

Despite the clarity of SMFM's clinical position, critical operational and legal questions remain unanswered:

What to watch

In the coming months, several key indicators will reveal the practical influence of the SMFM guidance:

This report relies on clinical guidance details reported by Medical Xpress on September 15, 2026, regarding the position paper published by the Society for Maternal-Fetal Medicine.